|
PL183378B1
(pl)
*
|
1995-03-27 |
2002-06-28 |
Assist Publ Hopitaux De Paris |
Zastosowanie fumagilolu i jego pochodnych do wytwarzania jelitowych środków przeciwinfekcyjnych
|
|
US6440445B1
(en)
*
|
1996-09-30 |
2002-08-27 |
Brigham & Women's Hospital |
Methods and compounds for treatment of abnormal uterine bleeding
|
|
DE69824750T2
(de)
*
|
1997-10-31 |
2005-07-07 |
Children's Medical Center Corp., Boston |
Methoden zur regulierung der grösse und des wachstums von durchblutetem normalem gewebe
|
|
CA2345276C
(en)
*
|
1998-10-09 |
2011-03-29 |
Ludwig Institute For Cancer Research |
Flt4 (vegfr-3) as a target for tumor imaging and anti-tumor therapy
|
|
US7141607B1
(en)
*
|
2000-03-10 |
2006-11-28 |
Insite Vision Incorporated |
Methods and compositions for treating and inhibiting retinal neovascularization
|
|
JPWO2004022082A1
(ja)
*
|
2002-09-04 |
2005-12-22 |
株式会社プロテイン・エクスプレス |
胚着床制御剤
|
|
WO2004103159A2
(en)
*
|
2003-05-14 |
2004-12-02 |
The Board Of Trustees Of The Leland Stanford Junior University |
Methods for modulating endometrium
|
|
EP1648575A4
(en)
*
|
2003-07-14 |
2009-09-16 |
Fusion Sport Internat Pty Ltd |
METHOD, DEVICE AND SYSTEM FOR SPORT TRAINING AND TESTING
|
|
WO2005042566A2
(en)
*
|
2003-08-29 |
2005-05-12 |
Children's Medical Center Corporation |
Antiangiogenicpeptides for treating or preventing endometriosis
|
|
US7524811B2
(en)
*
|
2003-08-29 |
2009-04-28 |
Children's Medical Center Corporation |
Anti-angiogenic peptides from the N-terminus of endostatin
|
|
CN102099491A
(zh)
*
|
2008-05-15 |
2011-06-15 |
北卡罗来纳-查佩尔山大学 |
调节血管生成的新靶标
|
|
EP2140860A1
(en)
*
|
2008-07-03 |
2010-01-06 |
Bayer Schering Pharma Oy |
An improved method of contraception
|
|
NZ590732A
(en)
*
|
2008-07-18 |
2012-09-28 |
Zafgen Inc |
Methods of treating an overweight or obese subject using fumagillin
|
|
US20100159506A1
(en)
*
|
2008-07-25 |
2010-06-24 |
Cellscape Corporation |
Methods and systems for genetic analysis of fetal nucleated red blood cells
|
|
WO2010065883A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Method of treating an overweight or obese subject
|
|
WO2010065877A2
(en)
|
2008-12-04 |
2010-06-10 |
Zafgen Corporation |
Methods of treating an overweight or obese subject
|
|
CN102639494B
(zh)
|
2009-10-09 |
2016-11-09 |
扎夫根公司 |
砜化合物及其制备和使用方法
|
|
WO2011085198A1
(en)
|
2010-01-08 |
2011-07-14 |
Zafgen Corporation |
Metap-2 inhibitor for use in treating benign prostatic hypertrophy (bph)
|
|
CA2786603C
(en)
|
2010-01-08 |
2018-02-20 |
James E. Vath |
Fumagillol type compounds and methods of making and using same
|
|
RU2427325C1
(ru)
*
|
2010-01-29 |
2011-08-27 |
Государственное образовательное учреждение высшего профессионального образования "Астраханская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО АГМА Росздрава) |
Способ оценки эффективности лечения хронической плацентарной недостаточности в эксперименте
|
|
US8774488B2
(en)
|
2010-03-11 |
2014-07-08 |
Cellscape Corporation |
Method and device for identification of nucleated red blood cells from a maternal blood sample
|
|
US20130266578A1
(en)
|
2010-04-07 |
2013-10-10 |
Thomas E. Hughes |
Methods of treating an overweight subject
|
|
CN103079567A
(zh)
|
2010-04-17 |
2013-05-01 |
拜尔健康护理有限责任公司 |
用于疾病和病症的治疗和预防的氟取代的ω-羧基芳基二苯脲的合成代谢产物
|
|
EP2595628A1
(en)
|
2010-07-19 |
2013-05-29 |
Bayer HealthCare LLC |
Drug combinations with fluoro-substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
|
|
CN103249735B
(zh)
|
2010-07-22 |
2016-04-06 |
扎夫根股份有限公司 |
三环化合物及其制备和使用方法
|
|
PH12013500934A1
(en)
|
2010-11-09 |
2022-10-24 |
Zafgen Inc |
Crystalline solids of a metap-2 inhibitor and methods of making and using same
|
|
BR112013013411A2
(pt)
|
2010-11-29 |
2016-09-13 |
Zafgen Inc |
tratamento de obesidade usando administração não diária de 6-0-(4-dimetilaminoetxi) cinamoil fumagilol
|
|
CN103402989B
(zh)
|
2011-01-26 |
2016-04-06 |
扎夫根股份有限公司 |
四唑化合物及其制备和使用方法
|
|
JP5876513B2
(ja)
|
2011-03-08 |
2016-03-02 |
ザフゲン，インコーポレイテッド |
オキサスピロ［２．５］オクタン誘導体および類似体
|
|
CA2835195A1
(en)
|
2011-05-06 |
2012-11-15 |
Zafgen, Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
US9290472B2
(en)
|
2011-05-06 |
2016-03-22 |
Zafgen, Inc. |
Partially saturated tricyclic compounds and methods of making and using same
|
|
MX343688B
(es)
|
2011-05-06 |
2016-11-16 |
Zafgen Inc |
Compuestos tricíclicos de sulfonamida y pirazolo y métodos para su fabricación y uso.
|
|
EP2763671A2
(en)
|
2011-10-03 |
2014-08-13 |
Zafgen, Inc. |
Methods of treating age related disorders
|
|
CA2861390A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfonamide compounds and methods of making and using same
|
|
WO2013109735A1
(en)
|
2012-01-18 |
2013-07-25 |
Zafgen, Inc. |
Tricyclic sulfone compounds and methods of making and using same
|
|
BR112014027808A2
(pt)
|
2012-05-07 |
2017-06-27 |
Zafgen Inc |
sal polimórfico do sal de oxalato de 6-o-(4-dimetilaminoetoxi) cinaroil fumagilol e métodos de produção e utilização do mesmo
|
|
CN104363905A
(zh)
|
2012-05-08 |
2015-02-18 |
扎夫根股份有限公司 |
用metap2抑制剂治疗下丘脑性肥胖
|
|
KR20150016534A
(ko)
|
2012-05-09 |
2015-02-12 |
자프겐 인크. |
푸마지롤형 화합물 및 이의 제조 및 사용 방법
|
|
CA2890342A1
(en)
|
2012-11-05 |
2014-05-08 |
Zafgen, Inc. |
Tricyclic compounds and methods of making and using same
|
|
SG11201503521QA
(en)
|
2012-11-05 |
2015-06-29 |
Zafgen Inc |
Methods of treating liver diseases
|
|
AU2013337288A1
(en)
|
2012-11-05 |
2015-05-21 |
Zafgen, Inc. |
Tricyclic compounds for use in the treatment and/or control of obesity
|
|
MX362391B
(es)
|
2013-03-14 |
2019-01-15 |
Zafgen Inc |
Métodos de tratamiento de enfermedad renal y otros trastornos.
|
|
CN106432255A
(zh)
|
2015-08-11 |
2017-02-22 |
扎夫根公司 |
烟曲霉素醇螺环化合物和制备和使用其的方法
|
|
AR105671A1
(es)
|
2015-08-11 |
2017-10-25 |
Zafgen Inc |
Compuestos heterocíclicos de fumagillol y sus métodos de elaboración y uso
|